Research progress on the relationship between lung cancer drug-resistance and microRNAs

This is a review paper for the analysis and prediction of lung cancer drug resistance. We explore several computational methods, that can provide, biological insights for the analysis, visualization and prediction of lung cancer drug resistance.

Download Full-text

Computational Methods for the Analysis and Prediction of EGFR-mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects

IEEE/ACM Transactions on Computational Biology and Bioinformatics ◽

10.1109/tcbb.2022.3141697 ◽

2022 ◽

pp. 1-1

Author(s):

Rizwan Qureshi ◽

Bin Zou ◽

Tanvir Alam ◽

Jia Wu ◽

Victor Lee ◽

...

Keyword(s):

Lung Cancer ◽

Drug Resistance ◽

Drug Design ◽

Computational Methods ◽

Cancer Drug ◽

Future Prospects ◽

Cancer Drug Resistance ◽

Recent Advances ◽

Egfr Mutated ◽

Design Challenges

Download Full-text

Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients

Oncotarget ◽

10.18632/oncotarget.17715 ◽

2017 ◽

Vol 8 (40) ◽

pp. 67056-67081 ◽

Cited By ~ 12

Author(s):

Leonel Armas-López ◽

Patricia Piña-Sánchez ◽

Oscar Arrieta ◽

Enrique Guzman de Alba ◽

Blanca Ortiz-Quintero ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Drug Resistance ◽

Cancer Patients ◽

Cancer Drug ◽

Lung Cancer Patients ◽

Cancer Drug Resistance

Download Full-text

Quest of EMT and CSC

Journal of Clinical and Medical Research ◽

10.37191/mapsci-2582-4333-1(2)-008 ◽

2019 ◽

Author(s):

Shihori Tanabe

Keyword(s):

Drug Resistance ◽

Stem Cell ◽

Cancer Progression ◽

Epithelial Mesenchymal Transition ◽

Cancer Therapeutics ◽

Cancer Drug ◽

Phenotypic Change ◽

Mesenchymal Transition ◽

Cancer Drug Resistance ◽

The Relationship

Epithelial-mesenchymal transition (EMT), an important phenotypic change from epithelial to mesenchymal like cells, has the increasing impact for cancer progression in terms of the involvement in cancer stem cell (CSC). The EMT-featured cells and CSCs are important factors for the acquisition of cancer drug resistance. The understanding of EMT program activation is important for targeting CSCs in cancer therapy. The relationship between EMT and CSC in cancer therapeutics is focused in the editorial.

Download Full-text